心脈醫療(688016.SH)業績快報:2020年度淨利升51.4%至2.15億元
格隆匯2月26日丨心脈醫療(688016.SH)公佈2020年度業績快報,報吿期內,公司實現營業總收入4.70億元,較上年同期增長40.91%;實現歸屬於上市公司股東的淨利潤2.15億元,較上年同期增長51.40%。報吿期末,公司總資產13.76億元,較期初增長19.07%;歸屬於母公司所有者權益12.34億元,較期初增長15.76%。
報吿期內,受新冠肺炎疫情的影響,一季度醫療機構的手術開展受到較大限制,自二季度開始國內疫情逐步好轉,醫療機構運轉亦逐步恢復如常,公司業務亦逐步恢復,報吿期內公司整體業務持續保持良好增長態勢。其中,公司2017下半年上市的Castor分支型主動脈覆膜支架及輸送系統在報吿期內持續保持快速增長;Minos腹主動脈覆膜支架及輸送系統、ReewarmPTX藥物球囊擴張導管自上市以來,亦逐步推進招標入院進程,報吿期內貢獻收入增量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.